Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs4820674 | chr22:21298053 | A/G | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs4822700 | chr22:21300308 | T/C | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs4822707 | chr22:21303690 | G/T | 2.05E-5 | 178 | 12.93 | 31.68 | 25.2 | KM Plot |
PCPG | rs4823962 | chr22:50212566 | T/C | 0.000201 | 174 | 25.53 | 20.2 | 15.18 | KM Plot |
PCPG | rs4823963 | chr22:50223509 | C/T | 0.000153 | 177 | 25.47 | 24.53 | 15.18 | KM Plot |
PCPG | rs483304 | chr13:37499658 | T/C | 5.57E-5 | 173 | 56.35 | 24.23 | 25.47 | KM Plot |
PCPG | rs4845559 | chr1:153611600 | A/G | 0.000372 | 174 | 5.68 | 27.33 | 25.17 | KM Plot |
PCPG | rs4848466 | chr2:118524716 | T/C | 1.5E-5 | 178 | 25 | 30.33 | 11.65 | KM Plot |
PCPG | rs4848468 | chr2:118561373 | G/C | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs4849624 | chr2:118535721 | C/G | 1.67E-5 | 177 | 24.85 | 30.33 | 11.65 | KM Plot |
PCPG | rs4856618 | chr3:80475954 | T/C | 0.000295 | 177 | 25.17 | 25.43 | 25.47 | KM Plot |
PCPG | rs4856623 | chr3:80584399 | A/C | 3.23E-5 | 176 | 19.2 | 24.53 | 27.4 | KM Plot |
PCPG | rs4856624 | chr3:80622158 | A/T | 8.57E-5 | 178 | 26.53 | 23.43 | 25.17 | KM Plot |
PCPG | rs4859142 | chr3:182614493 | A/G | 0.000212 | 178 | 25.53 | 27.27 | 11.78 | KM Plot |
PCPG | rs4859252 | chr3:182615392 | T/A | 1.06E-5 | 174 | 25.87 | 27.2 | 11.78 | KM Plot |